Final Thoughts

EP: 1.The Mission Behind CAR T-cell Clinical Trials

EP: 2.Key Challenges within CAR T-cell Clinical Trials

EP: 3.Approaching Institutional Biosafety Committee Approval for CAR T-cell Therapy

EP: 4.FDA Regulations for CAR T-cell Therapy

EP: 5.The Future of Regulatory Processes in Cell and Gene Therapy

EP: 6.Site Selection for CAR T-cell Trials

EP: 7.Collaboration with Clinical Trial Sites

EP: 8.Patient Selection and Recruitment for Clinical Trials

EP: 9.Looking Towards the Future of CAR T-cell Trials

Now Viewing

EP: 10.Final Thoughts

The panelists provide their closing thoughts on CAR T-cell therapies and what they look forward to as these therapies become popular beyond cancer, extending to autoimmune diseases as well. There is hope to remove manufacturing bottleneck so patient demand and access can improve.